Table 1 Subcutaneous injection of AAT in healthy volunteers.
Subject | Age range | Sex | AAT implant time in situ | Excision timepoint | Surgical procedure | Injection volumes (sites) | Total dose |
|---|---|---|---|---|---|---|---|
01 | 60–69 y | M | 29 d | 4 wk | Panniculectomy | 1 cc (2) | 2 cc |
02a | 30–39 y | F | 12 d | 2 wk | Panniculectomy | 1 cc (2) | 2 cc |
03 | 50–59 y | F | 5 d | 1 wk | Abdominoplasty | 2 cc (1) | 2 cc |
04 | 20–29 y | F | 16 d | 2 wk | Abdominoplasty | 1 cc (2) | 2 cc |
05 | 50–59 y | F | 26 d | 4 wk | Panniculectomy | 1 cc (2) | 2 cc |
06 | 50–59 y | F | 6 d | 1 wk | Panniculectomy | 1 cc (2) | 2 cc |
07 | 40–49 y | F | 127 d | 18 wk | Abdominoplasty | 2 cc (1) | 2 cc |
08 | 60–69 y | F | 39 d | 6 wk | Panniculectomy | 1 cc (2), 2 cc (1) | 4 cc |
Mean | 48 y | 32.5 d | 2.25 cc | ||||
SD | 13.6 y | 40.0 d | 0.71 cc |
